Warning: Creating default object from empty value in /home/customer/www/americanhealthcouncil.org/public_html/wp-content/themes/enfold/config-templatebuilder/avia-shortcodes/slideshow_layerslider/slideshow_layerslider.php on line 28

Warning: session_start(): Cannot start session when headers already sent in /home/customer/www/americanhealthcouncil.org/public_html/wp-content/themes/enfold/config-templatebuilder/avia-shortcodes/masonry_entries/masonry_entries.php on line 56
Common Prostate Cancer Treatment May Increase Risk for Alzheimer's | American Health Council

Common Prostate Cancer Treatment May Increase Risk for Alzheimer’s

Common Prostate Cancer Treatment May Increase Risk for Alzheimer's - Health Council

Oncologists are taking a look at a common prostate cancer treatment, that may double the risk for Alzheimer’s disease. Although more research has to be done, they are closely taking a look into why this could be happening.

“It’s called androgen deprivation therapy, and it’s aimed at lowering levels of testosterone, the “male” hormone that fuels some types of prostate cancer.”

“The study of more than 16,000 men being treated for prostate cancer showed that those who got any kind of androgen deprivation therapy had nearly twice the risk of developing Alzheimer’s over the next 2 ½ years as men getting other treatments.”

“Those treated for more than a year had more than twice the risk of an Alzheimer’s diagnosis.”

Read the full article: Common Prostate Cancer Treatment May Double Risk for Alzheimer’s